Here are five things to know:
1. OrthoSensor raised $19 million in a private placement of Series C Preferred Stock.
2. Bridger Healthcare and The Tullis Growth Fund participated in the round.
3. The company plans to use proceeds to drive VERASENSE commercialization.
4. The VERASENSE technology is a disposable sensor-assisted total knee replacement instrument.
5. There is a two-year multicenter evaluation of the technology that will be presented at the 2015 American Academy of Orthopaedic Surgeons annual meeting.
“We have an exciting path forward and believe that the support of high-profile investors such as Bridger Healthcare and The Tullis Growth Fund illustrates broad potential impact of our technology in the future of orthopedics,” said OrthoSensor President and CEO Ivan Delevic.
More articles on orthopedic devices:
Bacteria-killing orthopedic implants? 5 things to know
Stimwave Technologies to hire 20 new employees
Blue Belt Technologies: 1st Navio-assisted joint procedure completed in Australia
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
